Ankur Drugs & Pharma Ltd. - Research Center
531683 ANKURDRUGS Group (T) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Mar ' 11 |
Sep ' 10 |
Sales |
68.78 |
76.44 |
76.65 |
271.42 |
552.57 |
Operating profit |
-3.71 |
-18.88 |
-17.75 |
14.40 |
118.21 |
Interest |
50.17 |
50.95 |
17.01 |
57.41 |
55.34 |
Gross profit |
-53.86 |
-69.81 |
-34.72 |
-42.60 |
63.27 |
EPS (Rs) |
-44.96 |
-80.74 |
-33.81 |
-52.15 |
18.07 |
Half yearly
results in details
|
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Mar ' 11 |
Sep ' 10 |
Other income |
0.03 |
0.02 |
0.04 |
0.41 |
0.40 |
Stock adjustment |
-0.55 |
5.39 |
13.29 |
46.80 |
-7.18 |
Raw material |
47.91 |
55.35 |
38.58 |
168.66 |
403.09 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
10.90 |
13.68 |
15.23 |
16.97 |
12.76 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
14.22 |
20.89 |
22.40 |
24.59 |
25.70 |
Provisions made |
- |
- |
4.90 |
- |
- |
Depreciation |
33.10 |
31.73 |
30.68 |
41.12 |
19.69 |
Taxation |
- |
31.27 |
- |
20.11 |
8.63 |
Net profit / loss |
-86.96 |
-156.17 |
-65.40 |
-100.87 |
34.95 |
Extra ordinary item |
- |
-23.37 |
- |
2.95 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
19.34 |
19.34 |
19.34 |
19.34 |
19.34 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
170.40 |
161.21 |
158.19 |
146.02 |
144.36 |
Agg.of non promotoholding (%) |
88.10 |
83.35 |
81.79 |
75.49 |
74.64 |
OPM (%) |
-5.40 |
-24.69 |
-23.16 |
5.31 |
21.39 |
GPM (%) |
-78.27 |
-91.30 |
-45.28 |
-15.67 |
11.44 |
NPM (%) |
-126.38 |
-204.26 |
-85.28 |
-37.11 |
6.32 |